Table 5.
TEAE, n (%) | Vismodegib 150 mg/day + pirfenidone ≤ 2403 mg/day (N = 21) |
---|---|
Total | 21 (100) |
Muscle spasms | 16 (76.2) |
Dysgeusia | 13 (61.9) |
Alopecia | 7 (33.3) |
Weight loss | 7 (33.3) |
Decreased appetite | 6 (28.6) |
IPF | 3 (14.3) |
Nausea | 3 (14.3) |
IPF idiopathic pulmonary fibrosis, TEAE treatment-emergent adverse event